LATTANZIO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 1.190
EU - Europa 1.095
AS - Asia 559
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 2.849
Nazione #
US - Stati Uniti d'America 1.189
CN - Cina 269
UA - Ucraina 215
IE - Irlanda 191
TR - Turchia 185
SE - Svezia 169
FR - Francia 146
GB - Regno Unito 138
DE - Germania 74
IT - Italia 71
IN - India 62
FI - Finlandia 48
SG - Singapore 37
RU - Federazione Russa 35
EU - Europa 3
VN - Vietnam 3
CZ - Repubblica Ceca 2
PL - Polonia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CA - Canada 1
CL - Cile 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MT - Malta 1
Totale 2.849
Città #
Chandler 262
Jacksonville 257
Dublin 191
Southend 132
Izmir 100
Dearborn 88
Princeton 85
Ashburn 72
Nanjing 70
Beijing 60
Wilmington 49
Cambridge 43
Altamura 26
Nanchang 24
Singapore 22
Kunming 17
Boardman 15
Washington 14
Hebei 13
Ann Arbor 12
Shenyang 12
Jiaxing 11
Moscow 11
Woodbridge 11
Augusta 10
Changsha 10
Los Angeles 10
Grevenbroich 8
New York 8
Norwalk 8
San Mateo 8
Chieti 7
Hangzhou 7
Tianjin 7
Falls Church 6
Munich 5
Hefei 4
Helsinki 4
Jinan 4
Lanzhou 4
Mountain View 4
Ningbo 4
Seattle 4
Tappahannock 4
Chongqing 3
Dong Ket 3
Milan 3
Rome 3
Boscotrecase 2
Cepagatti 2
Changchun 2
Chaoyang 2
Düsseldorf 2
Leawood 2
Modena 2
Perugia 2
Shanghai 2
Simi Valley 2
Bangalore 1
Bellante 1
Brno 1
Catania 1
Dallas 1
Durham 1
Fairfield 1
Fuzhou 1
Greifswald 1
Haikou 1
Houston 1
Hunedoara 1
Kraków 1
Lappeenranta 1
London 1
Louisville 1
Melita 1
Monmouth Junction 1
Newcastle Upon Tyne 1
Newcastle upon Tyne 1
Novokuznetsk 1
Olomouc 1
Orange 1
Qingdao 1
Quzhou 1
San Francisco 1
San Giacomo degli Schiavoni 1
San Nicola la Strada 1
Secaucus 1
Taizhou 1
Tokyo 1
Torino 1
Toronto 1
Vancouver 1
Villa Bartolomea 1
Walnut 1
Wuhan 1
Zgierz 1
Zhengzhou 1
Ürümqi 1
Totale 1.795
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 108
Pentraxin 3 and platelet activation in obese patients after gastric banding 107
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 100
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 89
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 87
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 87
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 82
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 80
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 80
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 79
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 77
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 76
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 76
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 75
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 75
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 72
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 70
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 70
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 69
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 68
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 68
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 67
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 65
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 65
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 62
Endogenous secretory rage in obese women: association with oxidative stress and platelet activation. Proc. 112° Congr. Naz. Soc It. Med. Interna, Roma, ottobre 2011, Int Emerg Med 6(S2): S186, 2011 59
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 59
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. 57
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 57
Determinants of Platelet Activation in Heart Failure. 57
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 57
Determinants of Platelet Activation in Heart Failure. 55
Soluble CD40L as an indicator of platelet Activation in Heart Failure 54
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 50
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype. 49
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 49
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 48
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 47
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 44
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 43
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 13
Totale 3.003
Categoria #
all - tutte 10.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020491 0 44 1 3 66 49 90 80 12 81 62 3
2020/2021269 44 4 45 0 10 59 6 8 42 43 3 5
2021/2022209 3 7 2 58 20 6 2 14 17 10 22 48
2022/2023655 46 97 46 67 64 127 33 45 101 7 9 13
2023/2024319 29 10 22 7 19 97 73 11 14 4 4 29
2024/202566 53 13 0 0 0 0 0 0 0 0 0 0
Totale 3.003